June 15, 1993 |
Large daily doses of Vitamin A can slow the slide toward blindness for patients with retinitis pigmentosa and may save years of eyesight for 100,000 Americans with the inherited affliction, a new study indicates. The same study also showed that large supplemental doses of Vitamin E actually accelerate the disease, said Dr. Eliot L. Berson, a Harvard Medical School researcher.
CALIFORNIA | LOCAL
November 16, 1986 |
A Van Nuys hospital Saturday inaugurated one of the nation's first centers providing medical and psychological support for people suffering from retinitis pigmentosa, an incurable form of blindness that afflicts as many as 400,000 Americans. Staffed by blind and sighted volunteers and hospital staff, the Retinitis Pigmentosa Vision Loss Adjustment Center at Valley Hospital Medical Center will be unusual.
CALIFORNIA | LOCAL
July 28, 1988 |
The money was supposed to go for eye-disease research. But the $50,553 in donations to Retinitis Pigmentosa International may have gone instead into the pockets of a trusted fund-raiser--a loss that may force the 15-year-old Woodland Hills-based charity to close, its founder said Wednesday. Los Angeles police said they want to question Daniel J. Sonners, the charity's former chief fund-raiser, who disappeared Monday after allegedly embezzling the money.
August 8, 1987 |
The stars on the dais Thursday night at the Dorothy Chandler Pavilion represented an odd mixture of Old and New Hollywood. Zsa Zsa Gabor was there, and sitting right next to her, Whoopi Goldberg. Charlton Heston and Ricardo Montalban were seated nearby, and so was Tina Yothers, the young co-star of "Family Ties." The occasion: a benefit concert by Stevie Wonder to raise money to fight retinitis pigmentosa, a degenerative eye disease that afflicts an estimated 400,000 Americans.
CALIFORNIA | LOCAL
April 13, 1985 |
The darkest day of Helen Harris' life was not the day she learned she had a rare eye disorder that might lead to total blindness. Instead, it came in 1973 when her 10-year-old son, Jimmy, came home bruised and crying on Halloween after trick-or-treating in her Woodland Hills neighborhood. "He had tripped over something that he hadn't seen and fallen and the other kids had laughed at him," Harris recalls. "Then someone had stolen his bag of candy and he couldn't see in the darkness to chase them."
February 14, 2013 |
The FDA on Thursday approved a bionic eye that improves vision for patients blinded by a rare eye condition called retinitis pigmentosa. The Argus II system , a video camera and transmitter mounted on eyeglasses, translates light and movement into electrical signals, which are sent directly to an array of electrodes implanted into a patient's retina. Clinical trials have demonstrated that for patients whose retinal cells have been ravaged by the genetic condition, the visual prosthetic device helps restore the ability to perform many daily activities.
March 19, 1992 |
Blind Ambition In 1973, actor Charlton Heston received a letter from a Woodland Hills woman saying she wanted his help to start an organization to fight retinitis pigmentosa. "I wrote that most people didn't even know how to pronounce the name much less anything about this genetic disease that causes degeneration of vision and finally blindness," the woman, Helen Harris, now recalls.
May 22, 2005 |
"Revelation" is the title of a new play by Christina Kokubo. And when it opens next month in Los Angeles, it may well be true to its title. That's because the cast will be made up entirely of blind actors, although the characters are all fully sighted. The play, about a group of people in a mystical land taking shelter during a crisis, was written and is being directed by Kokubo, who began teaching drama at the Braille Institute five years ago.
April 27, 2013 |
Robert Greenberg got tired of hearing from senior engineers that it wasn't possible to build his product idea: a bionic eye that gives sight to the blind. "A lot of the folks straight out of school didn't know any better, so I hired them instead," quipped Greenberg, chief executive of Second Sight Medical Products Inc., a Sylmar biotech company. "They didn't know how hard it was going to be, that it was impossible. And so they tried. " Greenberg can laugh now that he once thought developing the device would take a year and $1 million.